CoreWeave stock edges higher as new lawsuit filing and insider sale notice hit tape

CoreWeave stock edges higher as new lawsuit filing and insider sale notice hit tape

New York, Jan 22, 2026, 11:36 a.m. ET — Regular session

  • CoreWeave shares edged up roughly 1% in late morning trades following a turbulent week
  • A Form 144 filing revealed a major shareholder intends to offload roughly $26.8 million worth of shares
  • A law firm announced that a securities class action lawsuit has been filed against the company

CoreWeave shares edged up roughly 1% to $95.04 on Thursday, bouncing between $93.30 and $99.20 during the session. Investors digested new legal developments alongside a recent filing hinting at possible insider selling.

These moves are crucial given CoreWeave’s volatile intraday swings this week. The stock has grown increasingly reactive to any factor that increases supply or raises questions about disclosures.

This is particularly the case for fast-growing AI infrastructure stocks, where traders jump on filings and headlines before cash flow and capital spending figures even register.

Pomerantz LLP announced Thursday that it filed a securities class action lawsuit against CoreWeave and some of its officers in U.S. federal court in Texas. The suit targets investors who purchased CoreWeave securities from March 28, 2025, through Dec. 15, 2025. (PR Newswire)

Separately, a Form 144 filing revealed an intention to offload 281,250 shares via Morgan Stanley Smith Barney. The total market value is pegged at roughly $26.8 million, based on the filing summary. Under SEC Rule 144, affiliates must file a Form 144 when selling restricted or control securities. (Stock Titan)

The planned sale represents only a tiny fraction of the company’s 386.4 million shares outstanding, yet it follows a period marked by heavy trading activity. (Stock Titan)

CoreWeave ended Wednesday’s trading at $94.05, having dropped to a session low of $87.25 earlier, according to Yahoo Finance.

CNBC’s Jim Cramer called out the stock this week, noting, “CoreWeave’s stock is coming back,” Insider Monkey reported in a recap. (Insider Monkey)

The overhang remains a concern. Lawsuits tend to drag out, and if early investors start selling, it could weigh on the stock—especially since it has shown sharp drops on risk-off days.

The next major milestone for investors is CoreWeave’s upcoming quarterly report. Nasdaq currently estimates the earnings release around Feb. 9, but warns the date is algorithm-driven and subject to change. (Nasdaq)

Stock Market Today

  • Hedge Funds Slightly Increase Holdings in Medtronic (MDT) in Latest 13F Filings
    January 22, 2026, 11:51 AM EST. Medtronic PLC (MDT) was held by 13 of the 27 most recent 13F filers for the reporting period ending June 30, 2025. Among these hedge funds, five increased their MDT positions, six reduced them, and one initiated a new holding. Aggregate shares held by all reporting funds rose marginally by 0.18%, adding approximately 105,000 shares to a total of nearly 58.87 million. 13F filings report only long equity positions, excluding shorts, which limits the full insight into fund strategies. Analysts view aggregated changes across funds as more indicative of trends. Medtronic remains a focus for further research due to these aggregated fund movements, suggesting cautious interest among institutional investors in the S&P 500 component.
Western Digital (WDC) stock slides after wild swing as Wall Street lifts targets ahead of earnings
Previous Story

Western Digital (WDC) stock slides after wild swing as Wall Street lifts targets ahead of earnings

JPMorgan Chase stock rises as Trump’s 10% credit-card cap plan keeps banks on edge
Next Story

JPMorgan Chase stock rises as Trump’s 10% credit-card cap plan keeps banks on edge

Go toTop